ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Company-led Recall

Company-led drug alert Recivit Sublingual Tablets

Grunenthal Limited is recalling the affected batches below due to a manufacturing issue, there is a possibility that blisters from the above batches may contain missing and / or two tablets in a single blister cavity.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
3830791Recivit 133mcg tabs x 30Grunenthal Limited14628
3830809Recivit 267mcg tabs x 30Grunenthal Limited14630
3830759Recivit 400mcg tabs x 30Grunenthal Limited14632
3830767Recivit 533mcg tabs x 30Grunenthal Limited15025
3830775Recivit 800mcg tabs x 30Grunenthal Limited14636

Please note that we have only identified 4 potential customers who have received these affected products from Alliance Healthcare and those customers will be contacted directly. The affected customers must ensure they have a AHDL "Returns Authorisation" code before attempting to hand the product(s) to the driver.